Lipids & Metabolic

Older adults living in long-term care facilities experienced a similar risk of mortality and cardiovascular hospitalizations regardless of whether they were taking intensive or more moderate doses of statins, a retrospective study found.

High retail prices for diabetes test strips are driving a “gray market” in the U.S. as an increasing number of uninsured diabetics struggle to afford something they need as often as 10 times a day, the New York Times reports.

Long-term sufferers of post-traumatic stress disorder (PTSD) are at a higher risk for circulatory and metabolic diseases, especially if they’re men, according to research out of Siena, Italy.

Clinicians’ personal beliefs about the safety and efficacy of statins play a larger role in their likelihood of prescribing the medications than their knowledge of cholesterol guidelines, according to a study published Jan. 4 in the American Journal of Cardiology.

Smoking hookah could raise users’ risk of developing diabetes or becoming obese, the Telegraph has reported of a study out of Brighton and Sussex Medical School.

Early-onset menstruation in women could be a red flag for an increased risk of cardiovascular disease and metabolic difficulties later in life, according to a report published in PLOS One.

The extra butter, cream and fats that go into Christmas cooking may raise people’s risk of elevated cholesterol by up to six times immediately following the holidays, suggesting diagnoses of hypercholesterolemia should wait until later in the year, according to a Danish study published in Atherosclerosis.

The recent price cuts of the PCSK9 inhibitor alirocumab (Praluent) aren’t enough to make the cholesterol-lowering drug cost-effective compared to ezetimibe, according to an analysis published in the Jan. 1 issue of the Annals of Internal Medicine.

The Mediterranean diet nudged the DASH diet out of the top spot for the best overall diet of 2019 in rankings released Jan. 2 by U.S. News and World Report. Those two approaches shared the No. 1 billing last year.

A new feature for a personal diabetes management application leverages AI to predict the likelihood of a user experiencing a hypoglycemic event in the next one to four hours.

Patients with diabetes and peripheral artery disease (PAD) are significantly more likely than nondiabetics with PAD to die from cardiovascular causes or have a heart attack or stroke, according to a subanalysis of the EUCLID trial.

A Singapore-based research team is cautioning diabetics to be mindful of what apps, if any, they’re using to manage their condition after an analysis found the majority of such aids lack the ability to effectively monitor a patient’s diet, activity, medications, glucose and insulin.